+Search query
-Structure paper
Title | Development of clinically viable nonmuscle myosin II small molecule inhibitors |
---|---|
Journal, issue, pages | To Be Published |
Publish date | Jun 26, 2024 (structure data deposition date) |
![]() | Radnai, L. / Young, E.J. / Kikuti, C.M. / Hafenbreidel, M. / Stremel, R. / Lin, L. / Toth, K. / Pasetto, P. / Jin, X. / Geedy, M. ...Radnai, L. / Young, E.J. / Kikuti, C.M. / Hafenbreidel, M. / Stremel, R. / Lin, L. / Toth, K. / Pasetto, P. / Jin, X. / Geedy, M. / Partridge, J. / Patel, A. / Conlon, M. / Briggs, S. / Sweeney, L.H. / Sellers, J. / Krieger-Burke, T. / Rumbaugh, G. / Cameron, M.D. / Surman, M. / Houdusse-Juille, A. / Griffin, P.R. / Kamenecka, T.M. / Miller, C.A. |
![]() | Search PubMed |
Methods | X-ray diffraction |
Resolution | 2.581 Å |
Structure data | ![]() PDB-9fu2: |
Chemicals | ![]() ChemComp-ADP: ![]() ChemComp-VO4: ![]() ChemComp-MG: ![]() ChemComp-DMS: ![]() ChemComp-EDO: ![]() PDB-1ige: ![]() ChemComp-CL: ![]() ChemComp-HOH: |
Source |
|
![]() | MOTOR PROTEIN / Smooth Muscle Myosin II;MT-228;myosin modulator;addiction;therapy;drug design |